New report suggests only small risk of mobile phones causing cancer

NewsGuard 100/100 Score

"A committee of the International Commission on Non-Ionizing Radiation Protection has concluded after a comprehensive review that there is little cause for concern about the suggested link between mobile phone use and brain tumours," BMJ reports (Watts, 7/4).

The report, published in Environmental Health Perspectives, "stated that despite near universal mobile phone use, there had been no jump in the number of tumours" and "also identified flaws in many studies investigating a link," BBC News writes (Gallagher, 7/1).

"Concerns that the technology might be harmful to the health of the 4.6 billion people who use cell phones aren't likely to be put to rest soon, because data is limited and researchers can't prove the complete absence of an impact, the panel said," Bloomberg reports. The report did not "issue guidelines for cell-phone use and said more study is needed, after finding some evidence for an increased risk of glioma, or brain cancer," according to the news service (Hallam, 7/1).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Amgen plows ahead with costly, highly toxic cancer dosing despite FDA challenge